BDSX
What one share of Biodesix holds
Services – Medical Laboratories
Biodesix, Inc. (“Biodesix”, “we,” “us,” “our” or the “Company”) is a leading diagnostic solutions company. Our mission at Biodesix is to transform patient care and improve outcomes through personalized diagnostics that are timely, accessible, and address immediate clinical needs.
Biodesix’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $11.59 |
|---|---|
| Profit | −$3.13 |
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | −$2.28 |
| Cash and investments | $2.84 |
| Debt | $4.44 |
| Book value | $0.87 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $39.84 | −$31.54 | $1.64 | −$22.26 | — | $12.81 |
| 2022 | $18.15 | −$31.09 | $1.57 | −$22.93 | — | $5.31 |
| 2023 | $11.96 | −$12.70 | $5.58 | −$11.15 | — | $0.95 |
| 2024 | $11.02 | −$6.64 | $0.50 | −$8.02 | — | $2.87 |
| 2025 | $11.72 | −$4.67 | $0.03 | −$3.12 | — | −$0.30 |